Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure

NCT ID: NCT04534400

Last Updated: 2023-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-01

Study Completion Date

2024-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Automated quantification of the pulmonary volume impaired during acute respiratory failure could be helpful to assess patient severity during COVID-19 infection or perioperative medicine, for example.

This study aim at assessing the correlation between the amount of radiologic pulmonary alteration and the clinical severity in two clinical situation :

1. SARS-CoV-2 infections
2. Postoperative hypoxemic acute respiratory failure

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SARS-CoV-2 Infection Respiratory Failure With Hypoxia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with SARS-CoV-2 infection

thoracic CT-scan

Intervention Type RADIATION

Automated measurement

Patients with Postoperative hypoxemic respiratory failure

thoracic CT-scan

Intervention Type RADIATION

Automated measurement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

thoracic CT-scan

Automated measurement

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient with insurance covering
* patient admitted to the participating hospitals for SARS-CoV-2 infection or postoperative acute hypoxemic respiratory failure between 01/01/2019 and 05/11/2020

Exclusion Criteria

\- patient transferred to another hospital than the participating center during the 7 days following the CT scan
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VISIBLE PATIENT, E-MEDIA

UNKNOWN

Sponsor Role collaborator

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

HÔPITAUX UNIVERSITAIRES DE STRASBOURG, Hôpital de Hautepierre, Service de Réanimation Médicale

Strasbourg, , France

Site Status RECRUITING

Hôpitaux Universitaires de Nancy Service d'anesthésie réanimation Hôpital de Brabois

Vandœuvre-lès-Nancy, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eric NOLL, MD

Role: CONTACT

33388127076

Pierre DIEMUNSCH, MD

Role: CONTACT

33388125720

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eric NOLL, MD

Role: primary

33388127076

Pierre DIEMUNSCH, MD

Role: backup

33388125720

Claude MEISTELMAN, MD

Role: primary

33383154166

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7888

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

DECT Ventilation Imaging
NCT02377518 TERMINATED NA